MX6497E - Procedimiento para la produccion de microcapsulas que contienen microorganismos constituyentes de la flora intestinal - Google Patents

Procedimiento para la produccion de microcapsulas que contienen microorganismos constituyentes de la flora intestinal

Info

Publication number
MX6497E
MX6497E MX798500U MX850079U MX6497E MX 6497 E MX6497 E MX 6497E MX 798500 U MX798500 U MX 798500U MX 850079 U MX850079 U MX 850079U MX 6497 E MX6497 E MX 6497E
Authority
MX
Mexico
Prior art keywords
constituent
procedure
production
intestinal flora
microcapsules containing
Prior art date
Application number
MX798500U
Other languages
English (en)
Inventor
Tomaso Sozzi
Alfred Schrenk
Marcel Buhler
Original Assignee
Nestle Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nestle Sa filed Critical Nestle Sa
Publication of MX6497E publication Critical patent/MX6497E/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/745—Bifidobacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J13/00—Colloid chemistry, e.g. the production of colloidal materials or their solutions, not otherwise provided for; Making microcapsules or microballoons
    • B01J13/02—Making microcapsules or microballoons
    • B01J13/04—Making microcapsules or microballoons by physical processes, e.g. drying, spraying
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A61K9/1694—Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Biophysics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dispersion Chemistry (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicinal Preparation (AREA)
  • Manufacturing Of Micro-Capsules (AREA)
MX798500U 1978-12-05 1979-11-27 Procedimiento para la produccion de microcapsulas que contienen microorganismos constituyentes de la flora intestinal MX6497E (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH1239278A CH637297A5 (fr) 1978-12-05 1978-12-05 Microbille comprenant un microorganisme et son procede de fabrication.

Publications (1)

Publication Number Publication Date
MX6497E true MX6497E (es) 1985-06-21

Family

ID=4382571

Family Applications (1)

Application Number Title Priority Date Filing Date
MX798500U MX6497E (es) 1978-12-05 1979-11-27 Procedimiento para la produccion de microcapsulas que contienen microorganismos constituyentes de la flora intestinal

Country Status (10)

Country Link
US (1) US4332790A (es)
AU (1) AU526326B2 (es)
BE (1) BE880027A (es)
CH (1) CH637297A5 (es)
DE (1) DE2946723C2 (es)
ES (1) ES486575A1 (es)
FR (2) FR2443247A1 (es)
IT (1) IT1164075B (es)
MX (1) MX6497E (es)
SE (1) SE447540B (es)

Families Citing this family (78)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4919929A (en) * 1984-02-01 1990-04-24 Stolle Research & Development Corporation Mammal immunization
SE463598B (sv) * 1984-11-08 1990-12-17 Chemical Dynamics Sweden Ab Preparat, avsett att oeka vidhaeftningen av bakterier till mag-tarmkanalen hos maenniskor och djur, samt ett framstaellningsfoerfarande foer detta
US5597564A (en) * 1986-08-28 1997-01-28 Enzacor Properties Limited Method of administering a microgranular preparation to the intestinal region of animals
US5356625A (en) * 1986-08-28 1994-10-18 Enzacor Properties Limited Microgranular preparation useful in the delivery of biologically active materials to the intestinal regions of animals
US6024983A (en) * 1986-10-24 2000-02-15 Southern Research Institute Composition for delivering bioactive agents for immune response and its preparation
AU640349B2 (en) * 1988-08-02 1993-08-26 Borody, Thomas J Dr Treatment of gastro-intestinal disorders
US5443826A (en) * 1988-08-02 1995-08-22 Borody; Thomas J. Treatment of gastro-intestinal disorders with a fecal composition or a composition of bacteroides and E. Coli
ATE165738T1 (de) * 1988-08-02 1998-05-15 Gastro Services Pty Ltd Behandlung von gastro-intestinalen krankheiten
CA2071867A1 (en) * 1989-11-06 1991-05-07 Edith Mathiowitz Method for producing protein microspheres
US5213810A (en) * 1990-03-30 1993-05-25 American Cyanamid Company Stable compositions for parenteral administration and method of making same
US5292657A (en) * 1990-12-31 1994-03-08 Pioneer Hi-Bred International, Inc. Process for preparing rotary disc fatty acid microspheres of microorganisms
BR9107280A (pt) * 1990-12-31 1994-06-14 Pioneer Hi Bred Int Bactérias microencapsuladas em disco rotatório em ácido graxo, secas
US5599556A (en) * 1991-12-31 1997-02-04 Abbott Laboratories Prolamine coatings for taste masking
DE69219768T2 (de) * 1992-07-06 1997-08-28 Societe Des Produits Nestle S.A., Vevey Milchbakterien
ES2111625T3 (es) * 1992-07-06 1998-03-16 Nestle Sa Agente antigastritis.
EP0654273A1 (en) * 1993-11-18 1995-05-24 Harry H. Leveen Pharmaceutical product and method for treatment
US5733568A (en) * 1993-12-03 1998-03-31 Lafor Laboratories Limited Micro-encapsulated lactobacilli for medical applications
ZA942302B (en) * 1993-12-03 1995-09-29 Lafor Lab Ltd Viracidal bactericidal and spermicidal vaginal suppository
AU7265596A (en) * 1995-11-02 1997-05-22 Ed. Haas Nahrmittel Gesellschaft M.B.H. Probiotically acting formulations
EP0818529B1 (fr) * 1996-07-09 2005-06-22 Societe Des Produits Nestle S.A. Procédé de séchage par pulvérisation
US20060116330A1 (en) * 1997-07-08 2006-06-01 The Iams Company Methods of mimicking the metabolic effects of caloric restriction by administration of mannoheptulose
US20020035071A1 (en) * 1997-07-08 2002-03-21 Josef Pitha Mimicking the metabolic effects of caloric restriction by administration of glucose antimetabolites
US8563522B2 (en) * 1997-07-08 2013-10-22 The Iams Company Method of maintaining and/or attenuating a decline in quality of life
DE60125176T3 (de) * 2000-06-26 2015-07-23 Dsm Ip Assets B.V. Verbesserte Verfahren zum Hinzufügen mehrfach gesättigter Fettsäuren in Milch
AUPQ899700A0 (en) 2000-07-25 2000-08-17 Borody, Thomas Julius Probiotic recolonisation therapy
RU2171672C1 (ru) * 2000-08-31 2001-08-10 Московская медицинская академия им. И.М. Сеченова Способ получения микрокапсулированных форм лактобактерий
US20050266069A1 (en) * 2002-09-06 2005-12-01 Simmons Donald L Stable probiotic microsphere compositions and their methods of preparation
US7517681B2 (en) * 2003-01-29 2009-04-14 Biogaia Ab Selection and use of lactic acid bacteria for reducing dental caries and bacteria causing dental caries
US20050100559A1 (en) * 2003-11-07 2005-05-12 The Procter & Gamble Company Stabilized compositions comprising a probiotic
US8877178B2 (en) 2003-12-19 2014-11-04 The Iams Company Methods of use of probiotic bifidobacteria for companion animals
US20050158294A1 (en) * 2003-12-19 2005-07-21 The Procter & Gamble Company Canine probiotic Bifidobacteria pseudolongum
US8894991B2 (en) 2003-12-19 2014-11-25 The Iams Company Canine probiotic Lactobacilli
US20050152884A1 (en) * 2003-12-19 2005-07-14 The Procter & Gamble Company Canine probiotic Bifidobacteria globosum
US7785635B1 (en) 2003-12-19 2010-08-31 The Procter & Gamble Company Methods of use of probiotic lactobacilli for companion animals
DE102004004030A1 (de) * 2004-01-27 2005-08-18 Mars Inc. Nahrungsmittelerzeugnis und Verfahren zu dessen Herstellung
ES2607988T3 (es) * 2005-05-31 2017-04-05 Iams Europe B.V. Bifidobacterias probióticas felinas
ATE512211T1 (de) * 2005-05-31 2011-06-15 Iams Company Feline probiotische lactobacilli
US8221809B2 (en) * 2006-06-22 2012-07-17 Martek Biosciences Corporation Encapsulated labile compound compositions and methods of making the same
ES2551719T3 (es) 2007-02-01 2015-11-23 Iams Europe B.V. Procedimiento para disminuir la inflamación y el estrés en un mamífero usando antimetabolitos de glucosa, aguacate o extractos de aguacate
BE1018007A5 (fr) * 2008-02-21 2010-03-02 Van Lidth De Jeude Jehan Lienart Enrobage de microorganismes.
US9771199B2 (en) 2008-07-07 2017-09-26 Mars, Incorporated Probiotic supplement, process for making, and packaging
DK2381799T3 (en) * 2009-01-27 2018-10-22 Probiotical Spa PROBIOTIC SUPPLEMENT WITH CHOCOLATE TASTE
IT1400821B1 (it) * 2009-03-09 2013-07-02 Probiotical Spa Sospensione oleosa contenente batteri probiotici per uso pediatrico
EP2251021B1 (en) 2009-05-11 2012-02-22 Nestec S.A. Prevention and treatment of allergic diarrhoea
US10104903B2 (en) 2009-07-31 2018-10-23 Mars, Incorporated Animal food and its appearance
DK2289527T3 (en) 2009-08-25 2018-04-23 Nestec Sa BIFIDOBACTERIUM LONGUM AND FUNCTIONAL GI DISEASES
IT1398648B1 (it) * 2010-03-09 2013-03-08 Probiotical Spa Prodotto alimentare comprendente batteri probiotici rivestiti con un rivestimento di origine vegetale.
NZ607043A (en) 2010-08-04 2015-05-29 Borody Thomas J Compositions for fecal floral transplantation and methods for making and using them and devices for delivering them
IT1403661B1 (it) 2011-01-28 2013-10-31 Probiotical Spa Composizione effervescente in forma solida per uso in applicazioni vaginali per il trattamento di infezioni vaginali.
CA2829385C (en) 2011-03-09 2021-07-13 Michael J. Sadowsky Compositions and methods for transplantation of colon microbiota
US20140065116A1 (en) * 2011-03-17 2014-03-06 Giovanni Mogna Probiotic bacteria having antioxidant activity and use thereof
ITMI20110792A1 (it) 2011-05-09 2012-11-10 Probiotical Spa Ceppi di batteri appartenenti al genere bifidobacterium per uso nel trattamento della ipercolesterolemia.
ITMI20110791A1 (it) 2011-05-09 2012-11-10 Probiotical Spa Ceppi di batteri in grado di metabolizzare gli ossalati.
ITMI20110793A1 (it) 2011-05-09 2012-11-10 Probiotical Spa Ceppi di batteri probiotici e composizione sinbiotica contenente gli stessi destinata alla alimentazione dei neonati.
ITRM20110477A1 (it) 2011-09-09 2013-03-10 Giovanni Mogna Composizione comprendente n-acetilcisteina e/o lisozima microincapsulato gastroprotetto in associazione con batteri probiotici in grado di ripristinare l'effetto barriera proprio dello stomaco che viene perso durante il trattamento farmacologico dell
ITMI20111718A1 (it) 2011-09-23 2013-03-24 Probiotical Spa Un materiale impermeabile alla umidita e allo ossigeno per confezionare prodotti dietetici, cosmetici e specialita medicinali.
DE102012008271A1 (de) 2012-04-23 2013-10-24 Human Nutrition Gmbh Kleingebäck zur Unterstützung der Gewichtsreduktion
WO2013176774A1 (en) 2012-05-25 2013-11-28 Arizona Board Of Regents Microbiome markers and therapies for autism spectrum disorders
CN103690490B (zh) * 2012-08-23 2017-11-17 尼奥克斯(文莱)控股有限公司 基于微囊化化学试剂延时产生一氧化氮的系统和方法
ITMI20130793A1 (it) 2013-05-14 2014-11-15 Probiotical Spa Composizione comprendente batteri lattici per uso nel trattamento preventivo e/o curativo delle cistiti ricorrenti.
BR112017024264B1 (pt) 2015-05-14 2022-07-12 Crestovo Holdings Llc Composições para transplante de flora fecal e métodos de preparação e utilização das mesmas, e dispositivos para sua administração
PT3297644T (pt) 2015-05-22 2022-03-30 Univ Arizona State Métodos para tratar distúrbios do espetro do autismo e sintomas associados
ITUA20162013A1 (it) 2016-03-24 2017-09-24 Probiotical Spa Composizione a base di batteri lattici per il trattamento contemporaneo di infezioni vaginali di origine micotica e batterica.
US20170360848A1 (en) 2016-06-15 2017-12-21 Arizona Board Of Regents On Behalf Of Arizona State University Methods for treating autism spectrum disorder and associated symptoms
US10849936B2 (en) 2016-07-01 2020-12-01 Regents Of The University Of Minnesota Compositions and methods for C. difficile treatment
US20180036352A1 (en) 2016-08-03 2018-02-08 Crestovo Holdings Llc Methods for treating ulcerative colitis
WO2018071537A1 (en) 2016-10-11 2018-04-19 Crestovo Holdings Llc Compositions and methods for treating multiple sclerosis and related disorders
US10092601B2 (en) 2016-10-11 2018-10-09 Crestovo Holdings Llc Compositions and methods for treating multiple sclerosis and related disorders
WO2018071536A1 (en) 2016-10-11 2018-04-19 Crestovo Holdings Llc Compositions and methods for treating primary sclerosing cholangitis and related disorders
EP3606541A1 (en) 2017-04-05 2020-02-12 Crestovo Holdings LLC Compositions and methods for treating parkinson's disease (pd) and related disorders
US11040073B2 (en) 2017-04-05 2021-06-22 Finch Therapeutics Holdings Llc Compositions and methods for treating diverticulitis and related disorders
CA3064773A1 (en) 2017-05-26 2018-11-29 Crestovo Holdings Llc Lyophilized compositions comprising fecal microbe-based therapeutic agents and methods for making and using same
CN111328284A (zh) 2017-08-07 2020-06-23 芬奇治疗公司 用于维持和恢复健康的肠道屏障的组合物和方法
US11166990B2 (en) 2018-07-13 2021-11-09 Finch Therapeutics Holdings Llc Methods and compositions for treating ulcerative colitis
AU2019351017A1 (en) 2018-09-27 2021-04-29 Finch Therapeutics Holdings Llc. Compositions and methods for treating epilepsy and related disorders
CA3114973A1 (en) 2018-10-02 2020-04-09 Societe Des Produits Nestle S.A. Probiotic combination for treatment of inflammatory-related gastrointestinal disorders
CN113660941A (zh) 2018-12-21 2021-11-16 雀巢产品有限公司 用于治疗变态反应性疾病的益生菌组合
AU2020316330A1 (en) 2019-07-19 2022-01-06 Finch Therapeutics Holdings Llc. Methods and products for treatment of gastrointestinal disorders

Family Cites Families (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US952418A (en) * 1909-08-14 1910-03-15 Emil Collett Dietetic chocolate and cocoa.
US1758937A (en) * 1925-12-05 1930-05-20 George H Earp-Thomas Lactobacteria product
US1851165A (en) * 1927-05-16 1932-03-29 Stewart M Farr Lactobacillus acidophilus milk product and its method of manufacture
US1929085A (en) * 1932-12-01 1933-10-03 Erwin A A Suehs Method of preserving viable bacilli
US2369218A (en) * 1941-01-02 1945-02-13 George F Dick Preparations of scarlet fever toxin for administration by mouth
US2376333A (en) * 1941-02-03 1945-05-22 Univ California Method of preserving microorganisms
FR1128072A (fr) * 1955-06-22 1957-01-02 Biotic Procédé pour la préparation de cultures microbiennes destinées à être conservées
US2875130A (en) * 1956-11-20 1959-02-24 Smith Kline French Lab Method of preparing sustained release particles and the product of the method
GB825480A (en) * 1957-07-13 1959-12-16 Johann Carl Pflueger Improvements in or relating to ingestible dry micro-organism preparations and method for producing the same
US3265629A (en) * 1958-12-22 1966-08-09 Ncr Co Coating by phase separation
FR1290858A (fr) * 1961-02-08 1962-04-20 Franscoma Appareil destiné à la pulvérisation de produits ou de mélanges de produits solides
BE640616A (es) * 1962-12-19
FR2828M (fr) * 1963-03-01 1964-11-02 Lucien Nouvel Médicament renfermant des colibacilles antibiorésistants.
FR3626M (fr) * 1963-11-13 1965-10-18 Lucien Nouvel Médicament pour affections intestinales.
FR1398107A (fr) * 1964-03-26 1965-05-07 Produit auxiliaire pour la fabrication des pâtes
US4132753A (en) * 1965-02-12 1979-01-02 American Cyanamid Company Process for preparing oral sustained release granules
FR1514115A (fr) * 1966-08-19 1968-02-23 Procédé de conservation des bactéries et produits en résultant
FR1495040A (fr) * 1966-08-24 1967-12-18 Interfett Spezialfettprodukte Procédé et dispositifs pour transformer des graisses et des mélanges d'huiles et de graisses en une poudre fine à structure cristalline
FR1584757A (es) * 1967-06-01 1970-01-02
GB1271674A (en) 1968-07-09 1972-04-26 Nisshin Flour Milling Co Process and preparation for treating diarrhoea in pigs
FR1602543A (en) * 1968-10-28 1970-12-21 Therapeutic compns contng freeze dried bacteria
US3541204A (en) * 1968-12-02 1970-11-17 Ian Ramsay Sibbald Encapsulated biologically active materials for feeding to ruminants and process for the production thereof
US3856699A (en) * 1969-08-08 1974-12-24 Fuji Photo Film Co Ltd Process for producing capsules having walls of a waxy material
US3892880A (en) * 1969-08-19 1975-07-01 Erhard Grolitsch Method for the manufacture of crystalline, flowable, stable fat powders or mixtures of such fat powders with other powdery materials
JPS4910912B1 (es) * 1970-03-17 1974-03-13
JPS4945224B1 (es) * 1970-12-14 1974-12-03
US3959493A (en) * 1971-03-17 1976-05-25 Rumen Chemie, Ag Rumen bypass products comprising biologically active substances protected with aliphatic fatty acids
BE788554A (fr) * 1971-09-23 1973-01-02 Rech Applic Scient Sogeras S A Procede pour la fabrication de substances actives pulverisees protegeescontre un milieu biologique
US3823228A (en) * 1971-09-29 1974-07-09 Univ Illinois Tge virus vaccine
DE2209565A1 (de) * 1972-02-29 1973-09-13 Lothringer Muehlen Gmbh Verfahren und vorrichtung zur herstellung eines fettkonzentrates
FR2201837A1 (en) * 1972-07-31 1974-05-03 Petroles Cie Francaise Powdered milk substitutes - contg powdered protein-rich fermented micro-organism prod esp for animal feed
DE2253515C3 (de) * 1972-10-28 1978-07-06 Fa. E. Kampffmeyer, 2000 Hamburg Verfahren zur Überführung von geschmolzenen Substanzen, insbesondere von Fetten und Fettgemischen in pulverförmige Konzentrate durch Versprühen
GB1413186A (en) * 1973-06-27 1975-11-12 Toyo Jozo Kk Process for encapsulation of medicaments
US3957974A (en) * 1974-11-05 1976-05-18 Seikenkai Method for deodorization of excrements
JPS5231981A (en) * 1975-08-18 1977-03-10 Takeda Chem Ind Ltd Microcapsule preparation method
US3973053A (en) * 1975-09-24 1976-08-03 Scm Corporation Process for tempering beaded fat quickly
SU598629A1 (ru) 1976-08-16 1978-03-25 Московский Ордена Ленина И Ордена Трудового Красного Знамени Государственный Университет Им. М.В.Ломоносова Способ получени микрокапсул
DE2645444A1 (de) 1976-10-08 1978-04-13 Karl Dr Med Theurer Verfahren zur gewinnung von oral wirksamen arzneimitteln und impfstoffen aus primaer nicht darmwirksamen praeparaten
US4147773A (en) * 1977-12-12 1979-04-03 Morinaga Milk Industry Co., Ltd. Powdery composition comprising viable Bifidobacteria cells and lactulose
US4235871A (en) * 1978-02-24 1980-11-25 Papahadjopoulos Demetrios P Method of encapsulating biologically active materials in lipid vesicles

Also Published As

Publication number Publication date
FR2443279A1 (fr) 1980-07-04
FR2443247A1 (fr) 1980-07-04
FR2443279B1 (es) 1984-04-06
AU5329879A (en) 1980-07-10
BE880027A (fr) 1980-05-14
IT7950976A0 (it) 1979-12-03
SE447540B (sv) 1986-11-24
DE2946723C2 (de) 1987-04-09
CH637297A5 (fr) 1983-07-29
SE7909492L (sv) 1980-06-06
AU526326B2 (en) 1983-01-06
FR2443247B1 (es) 1983-04-29
US4332790A (en) 1982-06-01
ES486575A1 (es) 1980-10-01
DE2946723A1 (de) 1980-06-19
IT1164075B (it) 1987-04-08

Similar Documents

Publication Publication Date Title
MX6497E (es) Procedimiento para la produccion de microcapsulas que contienen microorganismos constituyentes de la flora intestinal
ES495559A0 (es) Un procedimiento para la produccion de microcapsulas
MX5862E (es) Procedimiento para la produccion de derivados de carboestirilo
ES495024A0 (es) Procedimiento para la produccion de 2-amino-5-hidroxi-1,2,3,4-tetrahidronaftalenos
AR221363A1 (es) Procedimiento para la produccion microbiologica de aceite
MX157845A (es) Procedimiento para la produccion de gas
ES486647A0 (es) Procedimiento para la produccion de macromonomeros
NO148596C (no) Fremgangsmaate for fremstilling av 1-hydroksylerte vitamin d forbindelser
MX161648A (es) Procedimiento para la produccion de hidrogeno
IT7928192A0 (it) Procedimento per la produzione di microcapsule.
ES504384A0 (es) Procedimiento para la produccion de la enzima colesterol-es-terasa
ES492142A0 (es) Procedimiento para la produccion de oxidasa de alcohol
SE7902251L (sv) Forfarande for framstellning av ol
ES488376A0 (es) Procedimiento para la produccion de compuestos fenil-azo-i- sotiazolilo
ES489768A0 (es) Procedimiento para la produccion de gas reductor para la reduccion de minerales
ES498016A0 (es) Procedimiento para la produccion de compuestos que contienen clorotriacinilo.
AR227701A1 (es) Procedimiento para la produccion de alpha-haloalquilamidas
AR223588A1 (es) Procedimiento para la produccion de nuevos esteres de acidos benzoimidazolilcarbamicos
AR232002A1 (es) Procedimiento para la produccion de butirato de n-butilo por reaccion de fermentacion
IT1127297B (it) Procedimento per la produzione di cumene
ES506792A0 (es) Procedimiento para la produccion de nuevos compuestos de lactama.
BR7900844A (pt) Instalacao para a producao de ozonio
AR229464A1 (es) Cloroacetanilidas,procedimiento para la produccion de estos compuestos,y composiciones herbicidas que los contienen
MX156288A (es) Mejoras a procedimiento para el blanqueado de material-celulosico
IT8022658A0 (it) Procedimento per la produzione difluoruro difluoroiodo acetilico.